Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs).
Purity:
95.0%
CAS Number:
[1690318-25-2]
* VAT and and shipping costs not included. Errors and price changes excepted